Recombinant Anti-ADCYAP1R1 × Anti-CRCP Bispecific Antibody (CrossMab) (CAT#: BSAB-LC003)
The anti-CGRP receptor/PAC1 antibody target both CGRP receptor and PAC1. By inhibiting the function of CGRP receptor and PAC1, the antibody can be potentially used in the treatment of chronic pain, migraine, and cluster headache.
Specific Inquiry
Specifications
- Target
- PAC1 receptor & CGRP receptor
- Type
- CrossMab
- Species Reactivity
- Human
- Target 1
- PAC1 receptor
- Host Species 1
- Human
- Target 2
- CGRP receptor
- Host Species 2
- Human
- Application
- ELISA
- Related Disease
- Chronic pain, Migraine, and Cluster headache
Target
- Target 1
- PAC1 receptor
- Gene ID
- 117
- UniProt ID
- A0A090N8F8
- Alternative Names
- ADCYAP1R1; adenylate cyclase activating polypeptide 1 (pituitary) receptor type I; PAC1; PAC1R; PACAPR; PACAPRI; pituitary adenylate cyclase-activating polypeptide type I receptor; PACAP-R1; PACAP receptor 1; PACAP type I receptor; pituitary adenylate cyclase activating polypeptide 1 receptor type I Hiphop
- Target 2
- CGRP receptor
- Gene ID
- 27297
- UniProt ID
- O75575
- Alternative Names
- CRCP; CGRP receptor component; RCP; RCP9; CGRPRCP; CGRP-RCP
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
Customer Reviews and Q&As
There are currently no Customer reviews or questions for BSAB-LC003. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.